ACTRN12614000518662撤回1 期
IPX233-B14-02: Evaluation of the pharmacokinetics and safety of multiple once-daily doses of IPX233 in healthy adult volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •Healthy volunteers between the ages of 18 and 45 years of age (inclusive) at the time of informed consent.
排除标准
- •Any history of drug or alcohol addiction or abuse.
- •Presence of a clinically significant disorder including acute or chronic infections, or a malignant neoplasm, and/or involving disease in one or more of these organ systems: cardiovascular, respiratory, renal, gastrointestinal, musculoskeletal, immunologic, hematologic, dermatologic, hepatic, reproductive, endocrine, neurologic, or psychiatric (including bipolar disorder), as determined by Clinical Investigators.
- •History of or clinical signs of narrow angle glaucoma, benign prostatic hypertrophy or urinary retention.
- •History of or clinical signs of any form of epilepsy or seizures.
研究者
相似试验
已完成
1 期
Evaluation of the Pharmacokinetics of Sublingual IPX237 in Healthy VolunteersDepressionACTRN12614000444684Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.24
已完成
1 期
Evaluation of the Pharmacokinetics and Safety of Dihydroergotamine Administered Via Two Intranasal Delivery DevicesMigraineACTRN12614000330640Impax Laboratories, Inc14
已完成
1 期
Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy VolunteersAttention Deficit Hyperactivity Disorder (ADHD)Neurological - Other neurological disordersACTRN12613001073796Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.20
已完成
不适用
Evaluation of the Pharmacokinetics of IPX231 (L0007, C0001) in Healthy SubjectsNeurological - Parkinson's diseaseParkinson's diseaseACTRN12613000973718Impax Laboratories, Inc.20
已完成
1 期
Evaluation of the Pharmacokinetics of IPX237 Formulations in Healthy VolunteersDepressionMental Health - DepressionACTRN12613001097730Impax Pharmaceuticals, A Division of Impax Laboratories, Inc.24